KAZIA THERAPEUTICS-SPON ADR (KZIA)

US48669G1058 - ADR

1.8  0 (0%)

After market: 1.7986 0 (-0.08%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2024
(2024-6-30)
2023
(2023-6-30)
2022
(2022-6-30)
2021
(2021-6-30)
2020
(2020-6-30)
Revenue
2.32M22.56K2.09K15.22M65.91K
Minority Interest Expense
N/AN/AN/AN/AN/A
Operating Expenses
29.51M24.15M25.38M21.56M12.20M
Research and Development
15.51M15.56M20.17M14.54M9.49M
Selling, General, and Administrative Expenses
13.56M8.58M5.23M7.02M3.69M
Operating Income
-27.19M-24.12M-25.38M-6.34M-12.13M
Interest Income/Expense
N/AN/AN/A0.00-163.18K
Other Income/Expense
0.00560.000.002.19K2.26K
Non Recurring Items
144.00K3.39M0.00-2.57M-474.56K
Income Before Taxes
-27.05M-20.74M-25.38M-8.91M-12.77M
Income Tax
-271.00K-271.09K-368.08K-484.35K-298.20K
Net Income
-26.78M-20.47M-25.01M-8.42M-12.47M
EBITDA
N/AN/AN/AN/A-11.05M
 
Per Share Data
EPS Diluted Total Ops
-6.71-73.33-124.69-47.26-10.80
 
Statistics
Profit Margin
-1154.22%-90714.45%-1196844.98%-55.32%-18915.90%
Operating Profit Margin
-1172.11%-106934.97%-1214456.46%-41.63%-18404.14%

All data in AUD

Charts